A detailed history of Livelsberger Financial Advisory transactions in Organon & Co. stock. As of the latest transaction made, Livelsberger Financial Advisory holds 134 shares of OGN stock, worth $2,205. This represents 0.05% of its overall portfolio holdings.

Number of Shares
134
Holding current value
$2,205
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$18.65 - $23.03 $2,499 - $3,086
134 New
134 $2.56 Million
Q4 2023

Mar 22, 2024

BUY
$10.95 - $17.32 $1,423 - $2,251
130 New
130 $1.88 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.19B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Livelsberger Financial Advisory Portfolio

Follow Livelsberger Financial Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Livelsberger Financial Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Livelsberger Financial Advisory with notifications on news.